Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 6
2002 8
2003 5
2004 2
2005 6
2006 4
2007 2
2008 7
2009 3
2010 4
2011 3
2012 3
2013 8
2014 2
2015 4
2016 5
2017 6
2018 11
2019 6
2020 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
Mazieres J, Drilon A, Lusque A, Mhanna L, Cortot AB, Mezquita L, Thai AA, Mascaux C, Couraud S, Veillon R, Van den Heuvel M, Neal J, Peled N, FrĆ¼h M, Ng TL, Gounant V, Popat S, Diebold J, Sabari J, Zhu VW, Rothschild SI, Bironzo P, Martinez-Marti A, Curioni-Fontecedro A, Rosell R, Lattuca-Truc M, Wiesweg M, Besse B, Solomon B, Barlesi F, Schouten RD, Wakelee H, Camidge DR, Zalcman G, Novello S, Ou SI, Milia J, Gautschi O. Mazieres J, et al. Among authors: mascaux c. Ann Oncol. 2019 Aug 1;30(8):1321-1328. doi: 10.1093/annonc/mdz167. Ann Oncol. 2019. PMID: 31125062 Free PMC article.
Immune evasion before tumour invasion in early lung squamous carcinogenesis.
Mascaux C, Angelova M, Vasaturo A, Beane J, Hijazi K, Anthoine G, Buttard B, Rothe F, Willard-Gallo K, Haller A, Ninane V, Burny A, Sculier JP, Spira A, Galon J. Mascaux C, et al. Nature. 2019 Jul;571(7766):570-575. doi: 10.1038/s41586-019-1330-0. Epub 2019 Jun 26. Nature. 2019. PMID: 31243362
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
Jeanson A, Tomasini P, Souquet-Bressand M, Brandone N, Boucekine M, Grangeon M, Chaleat S, Khobta N, Milia J, Mhanna L, Greillier L, Biemar J, Nanni I, Ouafik L, Garcia S, MaziĆØres J, Barlesi F, Mascaux C. Jeanson A, et al. Among authors: mascaux c. J Thorac Oncol. 2019 Jun;14(6):1095-1101. doi: 10.1016/j.jtho.2019.01.011. Epub 2019 Feb 6. J Thorac Oncol. 2019. PMID: 30738221 Free article.
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
LabbƩ C, Cabanero M, Korpanty GJ, Tomasini P, Doherty MK, Mascaux C, Jao K, Pitcher B, Wang R, Pintilie M, Leighl NB, Feld R, Liu G, Bradbury PA, Kamel-Reid S, Tsao MS, Shepherd FA. LabbƩ C, et al. Among authors: mascaux c. Lung Cancer. 2017 Sep;111:23-29. doi: 10.1016/j.lungcan.2017.06.014. Epub 2017 Jun 24. Lung Cancer. 2017. PMID: 28838393
Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.
Grangeon M, Tomasini P, Chaleat S, Jeanson A, Souquet-Bressand M, Khobta N, Bermudez J, Trigui Y, Greillier L, Blanchon M, Boucekine M, Mascaux C, Barlesi F. Grangeon M, et al. Among authors: mascaux c. Clin Lung Cancer. 2019 May;20(3):201-207. doi: 10.1016/j.cllc.2018.10.002. Epub 2018 Oct 11. Clin Lung Cancer. 2019. PMID: 30442524
Personalised medicine for nonsmall cell lung cancer.
Mascaux C, Tomasini P, Greillier L, Barlesi F. Mascaux C, et al. Eur Respir Rev. 2017 Nov 15;26(146):170066. doi: 10.1183/16000617.0066-2017. Print 2017 Dec 31. Eur Respir Rev. 2017. PMID: 29141962 Free article. Review.
TGFĪ± Promotes Chemoresistance of Malignant Pleural Mesothelioma.
Staumont B, Jamakhani M, Costa C, Vandermeers F, Sriramareddy SN, RedoutƩ G, Mascaux C, Delvenne P, Hubert P, Safari R, Willems L. Staumont B, et al. Among authors: mascaux c. Cancers (Basel). 2020 Jun 6;12(6):1484. doi: 10.3390/cancers12061484. Cancers (Basel). 2020. PMID: 32517259 Free PMC article.
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
Boyer A, Pasquier E, Tomasini P, Ciccolini J, Greillier L, Andre N, Barlesi F, Mascaux C. Boyer A, et al. Among authors: mascaux c. Eur Respir Rev. 2018 Mar 14;27(147):170098. doi: 10.1183/16000617.0098-2017. Print 2018 Mar 31. Eur Respir Rev. 2018. PMID: 29540495 Free article. Review.
95 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page